Participation of our group in a publication in Nature

Dr. Manuel Comabella and Dr. Xavier Montalban from our research group have contributed to the study “Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis” published in Nature this month (Nature 476, 214–219). This is probably the largest genetics study ever undertaken on Multiple Sclerosis and includes contributions from almost 250 researchers as members of the International Multiple Sclerosis Genetics Consortium and the Wellcome Trust Case Control Consortium.